Vector for in vitro mutagenesis and use thereof
 Site-directed in vitro mutagenesis is obtained utilizing a specially-engineered plasmid vector. The vector is engineered to contain an inactivated genetic marker which marker is capable of being reverted to functional expression. Additionally, the vector contains a second genetic marker, a polylinker region and an f1 replication origin. 
Promega Corporation
C
C12N
inventional
Martin K. David V.
Lewis Thompson